Therapeutic and cytotoxic effects of the novel antipsoriasis codrug, naproxyl-dithranol, on HaCaT cells

Molecular Pharmaceutics

Volumn 8, Issue 6, 2011, Pages 2398-2407

  Lau, Wing Man ^a   Ng, Keng Wooi ^a   White, Alex W ^a   Heard, Charles M ^a  

^a UNIVERSITY OF READING   (United Kingdom)

Author keywords

codrug; dithranol; inflammation; naproxen; prodrug; proliferation

Indexed keywords

ANTIPSORIASIS AGENT; CASPASE 3; CYCLINE; CYCLOOXYGENASE 2; DITHRANOL; KI 67 ANTIGEN; NAPROXEN; NAPROXYL DITHRANOL; UNCLASSIFIED DRUG;

ANTIINFLAMMATORY ACTIVITY; ARTICLE; CELL LINE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DOWN REGULATION; DRUG CYTOTOXICITY; DRUG EFFECT; DRUG SYNTHESIS; HUMAN; HUMAN CELL; KERATINOCYTE; PRIORITY JOURNAL; PROTEIN EXPRESSION; UPREGULATION;

ANTHRALIN; ANTI-INFLAMMATORY AGENTS; CELL LINE; CELL PROLIFERATION; CYCLOOXYGENASE 2; ESTERS; FLOW CYTOMETRY; HUMANS; IMMUNOHISTOCHEMISTRY; MOLECULAR STRUCTURE; NAPROXEN;

EID: 82955240648     PISSN: 15438384     EISSN: 15438392     Source Type: Journal    
DOI: 10.1021/mp200327k     Document Type: Article

References (29)

1. National Psoriasis Foundation. About psoriasis. http://www.psoriasis.org/ about/psoriasis/ (19 Jun 2011).
2. Gudjonsson, J. E.; Elder, J. T. Psoriasis: epidemiology Clin. Dermatol. 2007, 25 (6) 535-546 (Pubitemid 350087600)
3. Gordon, K. B.; Ruderman, E. M. The treatment of psoriasis and psoriatic arthritis: an interdisciplinary approach J. Am. Acad. Dermatol. 2006, 54 (3) S86-91
4. EMEA. Guideline on clinical investigation of medicinal products for the treatment of psoriatic arthritis; London, 2005.
5. Menter, A.; Griffiths, C. E. M. Current and future management of psoriasis Lancet 2007, 370 (9583) 272-84 (Pubitemid 47071926)
6. Lau, W. M.; White, A. W.; Gallagher, S. J.; Donaldson, M.; McNaughton, G.; Heard, C. M. Scope and limitations of the co-drug approach to topical drug delivery Curr. Pharm. Des. 2008, 14 (8) 794-802 (Pubitemid 351736437)
7. Lau, W. M.; Heard, C. M.; White, A. W. Design, synthesis and in vitro degradation of a novel co-drug of dithranol and naproxen; Cardiff University: Cardiff, 2008.
8. Lau, W. M.; White, A. W.; Heard, C. M. Topical delivery of a naproxen-dithranol co-drug: in vitro skin penetration, permeation, and staining Pharm. Res. 2010, 27 (12) 2734-42
9. Boukamp, P.; Petrussevska, R. T.; Breitkreutz, D.; Hornung, J.; Markham, A.; Fusenig, N. E. Normal keratinization in a spontaneously immortalized aneuploid human keratinocyte cell line J. Cell Biol. 1988, 106 (3) 761-71 (Pubitemid 18089976)
10. 2 generation and proliferation in the HaCaT cell line J. Nat. Prod. 2004, 67 (9) 1459-63 (Pubitemid 39298610)
11. Tse, W. P.; Che, C. T.; Liu, K.; Lin, Z. X. Evaluation of the anti-proliferative properties of selected psoriasis-treating Chinese medicines on cultured HaCaT cells J. Ethnopharmacol. 2006, 108 (1) 133-41 (Pubitemid 44498993)
12. Pol, A.; Bergers, M.; Schalkwijk, J. Comparison of antiproliferative effects of experimental and established antipsoriatic drugs on human keratinocytes, using a simple 96-well-plate assay In Vitro Cell. Dev. Biol.: Anim. 2003, 39 (1-2) 36-42 (Pubitemid 36944607)
13. Jang, H. S.; Oh, C. K.; Jo, J. H.; Kim, Y. S.; Kwon, K. S. Detection of telomerase activity in psoriasis lesional skin and correlation with Ki-67 expression and suppression by retinoic acid J. Korean Med. Sci. 2001, 16 (5) 623-9
14. Kawashima, K.; Doi, H.; Ito, Y.; Shibata, M.-A.; Yoshinaka, R.; Otsuki, Y. Evaluation of cell death and proliferation in psoriatic epidermis J. Dermatol. Sci. 2004, 35 (3) 207-14 (Pubitemid 39295695)
15. Sweet, W. L.; Smoller, B. R. Differential proliferation of endothelial cells and keratinocytes in psoriasis and spongiotic dermatitis J. Cutaneous Pathol. 1997, 24 (6) 356-63 (Pubitemid 27312016)
16. Hernandez, G. L.; Volpert, O. V.; Iniguez, M. A.; Lorenzo, E.; Martinez-Martinez, S.; Grau, R.; Fresno, M.; Redondo, J. M. Selective inhibition of vascular endothelial growth factor-mediated angiogenesis by cyclosporin A: roles of the nuclear factor of activated T cells and cyclooxygenase 2 J. Exp. Med. 2001, 193 (5) 607-20 (Pubitemid 32539557)
17. Stark, K.; Torma, H.; Oliw, E. H. Co-localization of COX-2, CYP4F8, and mPGES-1 in epidermis with prominent expression of CYP4F8 mRNA in psoriatic lesions Prostaglandins Other Lipid Mediators 2006, 79 (1-2) 114-25
18. Hawkey, C. J. COX-2 inhibitors Lancet 1999, 353 (9149) 307-14 (Pubitemid 29089366)
19. Leong, J.; Hughes-Fulford, M.; Rakhlin, N.; Habib, A.; Maclouf, J.; Goldyne, M. E. Cyclooxygenases in human and mouse skin and cultured human keratinocytes: association of COX-2 expression with human keratinocyte differentiation Exp. Cell Res. 1996, 224 (1) 79-87 (Pubitemid 26116890)
20. Chêne, G.; Dubourdeau, M.; Balard, P.; Escoubet-Lozach, L.; Orfila, C.; Berry, A.; Bernad, J.; Aries, M.-F.; Charveron, M.; Pipy, B. n-3 and n-6 Polyunsaturated fatty acids induce the expression of COX-2 via PPAR-γ activation in human keratinocyte HaCaT cells Biochim Biophys Acta, Mol. Cell Biol. Lipids 2007, 1771 (5) 576-89 (Pubitemid 46680522)
21. Eli, Y.; Przedecki, F.; Levin, G.; Kariv, N. A.; Raz, A. Comparative effects of indomethacin on cell proliferation and cell cycle progression in tumor cells grown in vitro and in vivo Biochem. Pharmacol. 2001, 61 (5) 565-71 (Pubitemid 32178490)
22. Porter, S. N.; Howarth, G. S.; Butler, R. N. Non-steroidal anti-inflammatory drugs and apoptosis in the gastrointestinal tract: potential role of the pentose phosphate pathways Eur. J. Pharmacol. 2000, 397 (1) 1-9 (Pubitemid 30323804)
23. Mahrle, G. Dithranol Clin. Dermatol. 1997, 15 (5) 723-37 (Pubitemid 27411475)
24. van de Kerkhof, P. Textbook of Psoriasis; Blackwell Publishing Ltd: Oxford, 2003.
25. Hawkey, C. J. COX-1 and COX-2 inhibitors Best Pract. Res. Clin. Gastroenterol. 2001, 15 (5) 801-20 (Pubitemid 32982367)
26. Cohen, G. M. Caspases: the executioners of apoptosis Biochem. J. 1997, 326, 1-16 (Pubitemid 27386911)
27. Hughes, A.; Smith, N. I.; Wallace, H. M. Polyamines reverse non-steroidal anti-inflammatory drug-induced toxicity in human colorectal cancer cells Biochem. J. 2003, 374 (2) 481-8 (Pubitemid 37094107)
28. Ashton, M.; Hanson, P. J. Disparate effects of non-steroidal anti-inflammatory drugs on apoptosis in guinea-pig gastric mucous cells: inhibition of basal apoptosis by diclofenac Br. J. Pharmacol. 2002, 135 (2) 407-16 (Pubitemid 34151173)
29. McGill, A.; Frank, A.; Emmett, N.; Leech, S. N.; Turnbull, D. M.; Birch-Machin, M. A.; Reynolds, N. J. The antipsoriatic drug anthralin accumulates in keratinocyte mitochondria, dissipates mitochondrial membrane potential, and induces apoptosis through a pathway dependent on respiratory competent mitochondria FASEB J. 2005, 19 (8) 1012-4 (Pubitemid 40827735)